|
Treatment of Suicidal Behavior and
Self-Injury in Borderline Personality Disorder
(Barbara Stanley, PhD; IRB # 3238)
This study provides Dialectical Behavior Therapy (DBT), supportive
psychotherapy, and/or fluoxetine (Prozac) to treat suicidal behavior and
self-injury in outpatients with borderline personality disorder.
Eligibility:
 |
Ages 18 to 50
|
 |
Meets criteria for Borderline Personality Disorder
|
 |
Has a history of at least two suicide attempts and/or self-injury
episodes (e.g., cutting, burning, head-banging, striking self, skin
picking), with at least one occurring within the last five years and at
least one in the last six months
|
 |
Stable living arrangement
|
 |
Not currently receiving optimal psychiatric treatment
|
 |
Willing and judged to be clinically able to be washed
out of psychotropic medications except for occasional benzodiazepine
(e.g., Ativan) use for 2-6 weeks prior to treatment
|
 |
Women cannot be pregnant and must be using an effective
form of birth control
|
Benefits to participant:
 |
Free, thorough clinical evaluation by doctoral-level psychologist
and/or psychiatrist
|
 |
No-cost outpatient treatment
|
For more information about participating, contact:
Barbara Stanley, PhD or Shelly Groves, BA
Phone: 212-543-6232
E-mail:
sgroves@neuron.cpmc.columbia.edu
|